Scrip    Clinica    RAJ    GCPJ    AnimalPharm
Email ID
Password
Forgotten your password?
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
News
|
Comment
|
Features
|
Analysis
|
Supplements & Reports
|
People
|
Events
|
Multimedia
|
Science Abstracts
|
Canadian events cast shadow over Japan's H1N1 vaccine plans
25 November 2009
Japan's government is launching a probe into the higher than normal incidence of anaphylaxis reported for one lot of a GlaxoSmithKline H1N1 vaccine in Canada, ...
Novartis to invest up to $2.3 billion in blood disorders, cancer and vaccines
25 November 2009
Novartis could pay the US firm Incyte up to $1.3 billion for the ex-US rights to its Janus kinase (JAK) inhibitor INCB18424 and the global rights to its ...
Merck & Co challenge to Vioxx securities lawsuit gets US high court hearing next week
25 November 2009
During oral arguments to the US Supreme Court on November 30th, Merck & Co will seek dismissal of a Vioxx securities fraud class action by arguing that ...
NICE gives a preliminary no to Avastin for bowel cancer
24 November 2009
NICE , the health technology appraisal body for England and Wales, has given a preliminary no to funding Roche 's Avastin (bevacizumab) for NHS patients with ...
 
Plethora to market Columbia's Striant in the UK
25 November 2009
The UK urology-focused firm Plethora Solutions is to market New Jersey-based Columbia Laboratories' testosterone replacement product Striant SR for men with hypogonadism in the UK. Striant SR is a ...
Biovitrum completes CBT divestment
25 November 2009
Biovitrum has completed the divestment of Cambridge Biotechnology (CBT) to Proximagen Neuroscience for a percentage of future revenues generated from CBT's pipeline. CBT's clinical stage projects ...
Oxagen raises £16 million in venture capital
25 November 2009
The UK firm Oxagen has completed a £16 million venture capital fundraising in a series C round led by new investor Novartis Venture Funds. Oxagen will use the proceeds to continue development of its ...
GSK and Gilead sign Asian commercialisation deal for Viread
25 November 2009
GlaxoSmithKline has acquired the rights to commercialise Gilead Sciences ' chronic hepatitis B (HBV) treatment Viread (tenofovir disoproxil fumarate) in China as part of an agreement covering four ...
 
US FDA to reivew extended-release Aricept NDA
25 November 2009
The US FDA has accepted for review Pfizer and Eisai 's NDA for a higher-dose 23mg once-daily extended-release formulation of their Alzheimer's drug Aricept (donepezil HCl extended release). The NDA ...
CHMP endorses Merck & Co fertility drug Elonva
24 November 2009
The CHMP has recommended that Merck & Co's Elonva (corifollitropin alfa injection) be approved in the EU for controlled ovarian stimulation (COS) in combination with a gonadotropin-releasing hormone ...
ViiV's Selzentry approved for treatment-naive HIV patients in US
24 November 2009
The US FDA has approved a label expansion of ViiV Healthcare's CCR5 antagonist Selzentry (maraviroc) to include treatment-naive HIV patients. The move follows an endorsement last month by an FDA ...
Ception and Cephalon stumble on mixed Cinquil data
24 November 2009
A Phase IIb/III study of Ception Therapeutics' Cinquil (reslizumab) for the treatment of paediatric eosinophilic oesophagitis (EOE) has yielded mixed results, hitting only one of two co-primary ...
 
Expect a long wait for FDA social media guidelines, experts say, as agency braves a new world
25 November 2009
Social media enthusiasts agree that the US FDA has a lot to consider in the aftermath of its November 12th-13th hearing on promotion of regulated medical products using the internet and social media ...
Global rate of new HIV infections down by 17%, says report
25 November 2009
The number of new HIV infections has fallen by 17% worldwide in the past eight years, including a 15% drop in new cases in sub-Saharan Africa, the region most heavily affected by the disease, says ...
Jubilant, UAB and Southern Research form joint venture
25 November 2009
Jubilant Organosys of India, the University of Alabama at Birmingham (UAB) and the Southern Research Institute have formed a joint venture that will focus on oncology and metabolic and infectious ...
Global Fund issues €17 million malaria grant for Brazil's Amazon
25 November 2009
Almost 50 towns in Brazil's Amazon region will receive increased prevention and treatment measures against malaria through a two-year €17 million grant from the Global Fund . The funding will support ...
 
PEOPLE
UK's CHM makes new appointments The UK's Commission on Human Medicines (CHM), an independent body which advises UK health ministers ...
MMV president and CEO resigns The not-for-profit public-private partnership Medicines for Malaria Venture (MMV) will take on new ...
Dr Bruce Carter joins Immune Design Dr Bruce Carter has joined Immune Design as executive chairman. He has experience in biotechnology ...
>> More People News...

EXPERT VIEW
The US public health insurance plan - a bridge too far?
25 November 2009
Ian Schofield
US healthcare reform has edged a little closer after the Senate voted to go ahead and debate its ...

Market Insight: GSK's strategies for emerging markets
25 November 2009

In an exclusive interview, Abbas Hussain, GlaxoSmithKline's president of emerging markets, reveals ...

Market Insight - Swine flu spreads across CEE, governments show mixed responses
23 November 2009

Swine flu epidemics are spreading across central and eastern Europe, and Ukraine has been hit ...

Market Insight - Clinical trials metrics tell all about pharma's R&D investment
19 November 2009

When examining the competitiveness of company pipelines and the extent of firms' commitment to R&D, ...

MULTIMEDIA
Scrip in a minute - week ending November 20th 20 November 2009

Get the Flash Player to see this player.

Commentary: Japan trims the fat
18 November 2009
Ian Haydock
Japan's famed wagyu beef is prized by gourmets because of its finely marbled nature, caused by thin ...

GSK's malaria vaccine sails towards uncharted territory
05 November 2009
Elizabeth Sukkar
GlaxoSmithKline will enter unknown regulatory waters when it eventually comes to seek approval of ...

Anti-obesity drugs: an inventor's perspective
20 November 2009
Asher Mullard
After years of anti-obesity disappointments, Orexigen's Contrave, Vivus's Qnexa and Arena's ...

CPhI Worldwide 2009
13 October 2009
Scrip's official preview of CPhI Worldwide, ICSE, P-MEC and BioPh 2009

Scrip's Stock Tracker: October 2009
05 November 2009
Ashley Yeo
Caution, fuelled by uncertainty, was the name of the game in October. The equity markets continued ...

EVENTS
27 November 2009
Newcastle, UK
01 December 2009
Singapore
06 December 2009
Dubai, United Arab Emirates
JOB OF THE WEEK Promote your vacancy here
DIRECTORY Scrip Directory 2009
© Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
RAJ
GCPJ
Animal Pharm